Neogen Corporation (NEOG)
NASDAQ: NEOG · IEX Real-Time Price · USD
12.01
-0.37 (-2.99%)
At close: Apr 15, 2024, 4:00 PM
12.11
+0.10 (0.83%)
After-hours: Apr 15, 2024, 7:53 PM EDT
Neogen Market Cap
Neogen has a market cap or net worth of $2.60 billion as of April 15, 2024. Its market cap has decreased by -31.72% in one year.
Market Cap
2.60B
Enterprise Value
3.32B
1-Year Change
-31.72%
Ranking
Category
Stock Price
$12.01
Market Cap Chart
Since December 1, 1998, Neogen's market cap has increased from $43.50M to $2.60B, an increase of 5,880.37%. That is a compound annual growth rate of 17.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 12, 2024 | 2.68B | -4.77% |
| Apr 11, 2024 | 2.82B | 4.00% |
| Apr 10, 2024 | 2.71B | -4.14% |
| Apr 9, 2024 | 2.82B | -9.28% |
| Apr 8, 2024 | 3.11B | 0.21% |
| Apr 5, 2024 | 3.11B | 1.92% |
| Apr 4, 2024 | 3.05B | -1.26% |
| Apr 3, 2024 | 3.09B | -1.59% |
| Apr 2, 2024 | 3.14B | -3.91% |
| Apr 1, 2024 | 3.27B | -4.44% |
| Mar 28, 2024 | 3.42B | 2.07% |
| Mar 27, 2024 | 3.35B | 3.07% |
| Mar 26, 2024 | 3.25B | -1.25% |
| Mar 25, 2024 | 3.29B | -0.13% |
| Mar 22, 2024 | 3.29B | -1.55% |
| Mar 21, 2024 | 3.35B | -0.96% |
| Mar 20, 2024 | 3.38B | 3.24% |
| Mar 19, 2024 | 3.27B | 0.26% |
| Mar 18, 2024 | 3.26B | -0.72% |
| Mar 15, 2024 | 3.29B | -0.46% |
| Mar 14, 2024 | 3.30B | -2.31% |
| Mar 13, 2024 | 3.38B | -1.95% |
| Mar 12, 2024 | 3.45B | -1.67% |
| Mar 11, 2024 | 3.51B | -1.10% |
| Mar 8, 2024 | 3.54B | -2.33% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Indivior | 2.80B |
| MoonLake Immunotherapeutics | 2.74B |
| MorphoSys AG | 2.72B |
| Janux Therapeutics | 2.72B |
| GoodRx Holdings | 2.70B |
| CG Oncology | 2.65B |
| Vera Therapeutics | 2.63B |
| Evotec SE | 2.58B |